Thrivent Financial For Lutherans cut its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 28.5% in the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 420,557 shares of the medical research company’s stock after selling 167,250 shares during the quarter. Thrivent Financial For Lutherans owned approximately 0.13% of Agilent Technologies worth $24,943,000 at the end of the most recent reporting period.
Other institutional investors also recently made changes to their positions in the company. Parallel Advisors LLC lifted its stake in Agilent Technologies by 5.3% during the second quarter. Parallel Advisors LLC now owns 2,623 shares of the medical research company’s stock worth $157,000 after purchasing an additional 131 shares during the last quarter. Trust Co. of Vermont lifted its stake in Agilent Technologies by 1.8% during the second quarter. Trust Co. of Vermont now owns 2,793 shares of the medical research company’s stock worth $166,000 after purchasing an additional 50 shares during the last quarter. Fiduciary Trust Co. purchased a new stake in Agilent Technologies during the second quarter worth approximately $186,000. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC lifted its stake in Agilent Technologies by 17.2% during the second quarter. Genovese Burford & Brothers Wealth & Retirement Plan Management LLC now owns 3,319 shares of the medical research company’s stock worth $196,000 after purchasing an additional 486 shares during the last quarter. Finally, Teacher Retirement System of Texas purchased a new stake in Agilent Technologies during the second quarter worth approximately $200,000.
ILLEGAL ACTIVITY WARNING: “Thrivent Financial For Lutherans Has $24.94 Million Stake in Agilent Technologies, Inc. (A)” was first published by Chaffey Breeze and is owned by of Chaffey Breeze. If you are reading this article on another publication, it was stolen and republished in violation of United States and international copyright & trademark legislation. The legal version of this article can be accessed at https://www.chaffeybreeze.com/2017/09/19/thrivent-financial-for-lutherans-has-24-94-million-stake-in-agilent-technologies-inc-a.html.
A has been the subject of several recent analyst reports. Robert W. Baird boosted their target price on Agilent Technologies from $57.00 to $62.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 24th. Jefferies Group LLC restated a “buy” rating and set a $66.00 target price on shares of Agilent Technologies in a research note on Wednesday, August 9th. Morgan Stanley boosted their target price on Agilent Technologies from $65.00 to $70.00 and gave the stock an “overweight” rating in a research note on Wednesday, May 24th. BidaskClub cut Agilent Technologies from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, June 13th. Finally, Barclays PLC restated a “buy” rating and set a $67.00 target price on shares of Agilent Technologies in a research note on Wednesday, July 19th. Three research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $63.91.
In related news, insider Patrick Kaltenbach sold 5,000 shares of the firm’s stock in a transaction that occurred on Thursday, July 13th. The stock was sold at an average price of $61.26, for a total value of $306,300.00. Following the sale, the insider now owns 45,138 shares of the company’s stock, valued at approximately $2,765,153.88. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Dominique Grau sold 13,007 shares of the firm’s stock in a transaction that occurred on Wednesday, August 16th. The stock was sold at an average price of $62.00, for a total value of $806,434.00. Following the completion of the sale, the insider now directly owns 60,098 shares in the company, valued at approximately $3,726,076. The disclosure for this sale can be found here. In the last quarter, insiders sold 170,720 shares of company stock valued at $10,795,039.
Agilent Technologies, Inc. (A) traded down 0.053% during midday trading on Tuesday, hitting $66.045. The stock had a trading volume of 100,970 shares. The stock has a 50-day moving average price of $62.57 and a 200 day moving average price of $58.21. Agilent Technologies, Inc. has a one year low of $42.92 and a one year high of $66.45. The firm has a market cap of $21.26 billion, a PE ratio of 34.061 and a beta of 1.30.
Agilent Technologies (NYSE:A) last issued its earnings results on Tuesday, August 15th. The medical research company reported $0.59 EPS for the quarter, topping the consensus estimate of $0.52 by $0.07. The company had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.09 billion. Agilent Technologies had a return on equity of 16.95% and a net margin of 14.36%. The business’s revenue was up 6.7% on a year-over-year basis. During the same quarter last year, the firm earned $0.49 EPS. On average, analysts predict that Agilent Technologies, Inc. will post $2.32 earnings per share for the current year.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A).
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.